Use access key #2 to skip to page content.
$10.51 -0.91 (-7.97%)
11/21/2008 12:23 PM

ISIS Pharmaceuticals, Inc. (ISIS)

CAPS Rating:
***

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

View All Commentary (ISIS)

Recs

0

Avatar springerrr (< 20) Submitted: 5/21/07 7:19 AM : Outperform Start Price: $10.09 ISIS Score: 55.01

I spent years, while a scientist in Pharma, working with Isis reagents. They work well in the liver and fat and now that Isis is turning its attention away from cancer, to some degree, and toward metabolic disease, I expect good news.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links